Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Innovate (VATE) EBT (2016 - 2025)

Innovate has reported EBT over the past 16 years, most recently at -$9.3 million for Q4 2025.

  • For Q4 2025, EBT rose 37.58% year-over-year to -$9.3 million; the TTM value through Dec 2025 reached -$61.5 million, down 84.13%, while the annual FY2025 figure was -$61.5 million, 84.13% down from the prior year.
  • EBT for Q4 2025 was -$9.3 million at Innovate, up from -$16.7 million in the prior quarter.
  • Over five years, EBT peaked at $11.4 million in Q2 2024 and troughed at -$41.8 million in Q1 2021.
  • A 5-year average of -$12.6 million and a median of -$12.2 million in 2022 define the central range for EBT.
  • Biggest five-year swings in EBT: skyrocketed 208.57% in 2024 and later crashed 247.37% in 2025.
  • Year by year, EBT stood at -$3.7 million in 2021, then plummeted by 116.22% to -$8.0 million in 2022, then decreased by 16.25% to -$9.3 million in 2023, then tumbled by 60.22% to -$14.9 million in 2024, then surged by 37.58% to -$9.3 million in 2025.
  • Business Quant data shows EBT for VATE at -$9.3 million in Q4 2025, -$16.7 million in Q3 2025, and -$16.8 million in Q2 2025.